Literature DB >> 29115492

Epithelial‑mesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3.

Shuping You1, Yun Guan2, Weihong Li1.   

Abstract

To investigate the inhibitory effects of DEK/insulin‑like growth factor II mRNA binding protein 3 (IMP3) on epithelial‑mesenchymal transition (EMT) in colorectal carcinoma cells. SW620 and SW480 cell lines were selected. DEK‑interfering lentivirus was transfected to knockdown DEK expression. Subsequently, MTT assays and flow cytometry were utilized to measure cell viability, and apoptosis, respectively. Cell invasion was detected using a Transwell assay. Quantitative polymerase chain reaction and western blot analysis were used to detect the expression of E‑cadherin, vimentin, and matrix metalloproteinase (MMP)‑9. Compared with the blank control, cells transfected with DEK‑interfering lentivirus demonstrated a remarkable reduction in cell viability (P<0.05). The apoptotic rate in the DEK‑interfering lentivirus group was significantly enhanced compared with the blank control group (P<0.05). In the DEK‑interfering lentivirus group, the expression of E‑cadherin was significantly elevated (P<0.05), while the expression of vimentin and MMP‑9 were significantly reduced in both cell lines (P<0.05). The results of the present study demonstrated that EMT of colorectal carcinoma cells was partially mediated by DEK, which likely affected the invasive ability of colorectal carcinoma cells. In addition, cell proliferation and apoptosis were susceptible to DEK silencing. The current study has provided experimental evidence for the treatment of colorectal carcinoma using DEK silencing.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29115492     DOI: 10.3892/mmr.2017.7943

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis.

Authors:  Tao Wu; Xuan Zhang; Lu Xing; Dingguo Pan; Ping Liu; Rong Ding; Renfang Yang; Xudong Yang; Yunfeng Li
Journal:  Dis Markers       Date:  2022-05-30       Impact factor: 3.464

2.  Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review.

Authors:  Muhammad Habiburrahman; Muhammad Prasetio Wardoyo; Stefanus Sutopo; Nur Rahadiani
Journal:  Mol Clin Oncol       Date:  2022-05-26

3.  DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.

Authors:  Kam-Fai Lee; Ming-Ming Tsai; Chung-Ying Tsai; Chung-Guei Huang; Yu-Hsiang Ou; Ching-Chuan Hsieh; Hsi-Lung Hsieh; Chia-Siu Wang; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2019-11-13       Impact factor: 5.923

4.  MicroRNA-325-3p contributes to colorectal carcinoma by targeting cytokeratin 18.

Authors:  Chuanfang Song; Xiujie Wang; Xinxin Zhao; Jiang Ai; Yixuan Qi; Aidong Chen
Journal:  Oncol Lett       Date:  2021-02-03       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.